© Reuters. FILE PHOTO: Pharmacist Susanne Wohlgemuth prepares Pfizer/BioNTech COVID-19 vaccinations on the Haus an der Linde nursing dwelling in Lichtentanne, Saxony, Germany December 27, 2020, the day when the nation begins its vaccination programme. Hendrik Schmidt/P
(Reuters) – The European Union’s medicines regulator stated on Monday it has began evaluating the usage of Pfizer Inc (NYSE:) and BioNTech’s COVID-19 vaccine in youngsters between the ages of 5 and 11.
The European Medicines Company stated it’s going to evaluate knowledge associated to the vaccine, often called Comirnaty, together with outcomes from an ongoing medical examine involving younger youngsters.
Fusion Media or anybody concerned with Fusion Media is not going to settle for any legal responsibility for loss or harm on account of reliance on the data together with knowledge, quotes, charts and purchase/promote indicators contained inside this web site. Please be totally knowledgeable concerning the dangers and prices related to buying and selling the monetary markets, it is likely one of the riskiest funding kinds doable.